B3galnt2 - beta-1,3-N-acetylgalactosaminyltransferase 2 Gene
Also Known as RGD1306946
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 291212
Summary
Predicted to enable acetylgalactosaminyltransferase activity. Predicted to be involved in protein O-linked glycosylation. Predicted to be located in endoplasmic reticulum. Predicted to be active in Golgi membrane. Human ortholog(s) of this gene implicated in congenital muscular dystrophy-dystroglycanopathy type A11. Orthologous to human B3GALNT2 (beta-1,3-N-acetylgalactosaminyltransferase 2). [provided by Alliance of Genome Resources, Apr 2022]
B3galnt2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001144851.2 | NP_001138323.1 | UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2 precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2 |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-E70139 | UDP-GalNAc:β-1,3-N-acetylgalactosaminyltransferase 2 | / | Unkown | |
| HY-RS01301 | B3GALNT2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service